Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-02

Clinical Trial Update: Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt® Eye Drops, 20 mg/ml [Phase 3]

View source ↗

Summary

A Phase 3 comparative trial comparing dorzol eye drops to Trusopt eye drops for primary open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzol (dorzolamide)
  • Trusopt (dorzolamide)

Snippet

Sponsor: Jadran Galenski laboratorij d.d. | Conditions: Primary Open Angle Glaucoma of Both Eyes | Phase 3 | Status: COMPLETED